Latest Issue

In this page you can find the latest issue of the journal

Latest issue

The latest issue of Chemistry Today explores strategic growth in pharmaceutical and chemical manufacturing, covering CDMO competitiveness, biocatalysis, HPAPI safety, regulatory data management, antibody-peptide conjugates, market resilience, AI-driven transformation, and patent strategies. It also presents expert insights on toxicology, supply chains, manufacturing innovation, and the ADC Symposium proceedings.

Don’t stop here. There’s more waiting below.

BROWSE THE FLIPBOOK

Content from magazine

“Contents from Magazine” offers curated articles and insights from the field of chemistry, focused on research, data, and scientific developments

View all content

Subscribe and get free unlimited access!

15K articles and news from our archive.

Subscribe now

EDITORIAL

Becoming the “Customer of Choice”: A Strategic Imperative for CDMOs and API Specialists

In today's rapidly evolving pharmaceutical ecosystem, the relationship between drug sponsors and their outsourced partners is more strategic than ever before. For companies engaged in active pharmaceutical ingredient development and manufacturing through…

by P. Paissoni • August 18, 2026

COVER STORY

Intelligence Amplified: A CDMO Perspective on Integrating R&D and Manufacturing

Artificial intelligence is reshaping pharmaceuticals industry-not through generic algorithms alone, but by addressing real scientific and manufacturing challenges with unprecedented speed and precision. At Asymchem, AI is to integrate across the R&D…

August 18, 2026

HPAPIS

Deriving health-based exposure limits for highly potent APIs: from regulatory expectation to expert toxicological judgement

Introduction The manufacture of medicinal products in shared facilities is an established industrial practice, but it requires a scientifically justified control strategy to prevent cross contamination. If an active substance is unintentionally…

by C. Gazerro • August 18, 2026

HPAPIS

HPAPI Management: From Categorization to Prevention – Practical Insights from the Spanish NTP 1104 & 1105 Framework

Introduction Highly Potent Active Pharmaceutical Ingredients (HPAPIs) have gained strategic importance across multiple therapeutic areas, including oncology, immunology, CNS, cardiovascular, ophthalmology and respiratory indications, as well as in emerging fields such as…

by G. A. Estruch • August 19, 2026

MARKET TRENDS

Scaling, Adapting and Partnering: How Europe’s Chemical Sector Can Stay Competitive in a Changing World

At Chemspec Europe 2026, I joined a panel with industry leaders to discuss a question increasingly shaping the future of Europe's chemical sector: how can the industry remain globally competitive as the…

by N. Huther • August 19, 2026

REGULATION

Regulatory affairs as the connective tissue of pharmaceutical product data

Arguably no pharma function has as complete a picture of a medicine across its full lifecycle as Regulatory Affairs (RA). This is because RA sits at the end of every data chain,…

by H. van Leeuwen, I. Crone • August 19, 2026

ANTIBODY-PEPTIDE CONJUGATES

Advancing Antibody–Peptide Conjugates Through Controlled Conjugation and High Product Homogeneity

Introduction Antibody–peptide conjugates (APCs) are gaining significant attention as a next-generation bioconjugate modality that combines the selectivity of monoclonal antibodies with the biological activity of therapeutic peptides (1). By integrating these two…

by X. Tang, Y. Li, Y. Shi, Z. Wang, W. Shi • August 19, 2026

COLUMN: API OF THE MONTH

Baxdrostat (Baxfendy)

Selectively blocking aldosterone production has been one of the harder problems in cardiovascular medicinal chemistry. For decades, hyperaldosteronism and resistant hypertension were managed with mineralocorticoid receptor antagonists, which work but carry systemic…

by R. Souza • August 19, 2026

ARTIFICIAL INTELLIGENCE

From data to decisions: How AI is transforming supply chains in chemical and pharmaceutical manufacturing

Introduction Supply chains in the chemical and pharmaceutical industries are becoming increasingly volatile, complex and regulated. Recent geopolitical tensions and trade policy shifts have added pressure to pharmaceutical supply chains, including active…

by S. Navi Nejand • August 20, 2026

ARTIFICIAL INTELLIGENCE

AI at Enterprise Scale: Inside Pharma’s Manufacturing Transformation

Introduction: The Digital Maturity Paradox The global pharmaceutical and biopharmaceutical manufacturing sectors stand at a critical crossroads in 2026. Capital investment in digital transformation, machine learning, and cloud analytics has reached historic…

by J. M. Geoffroy • August 20, 2026

ARTIFICIAL INTELLIGENCE

Artificial Intelligence in the Biopharma Industry

Artificial Intelligence (AI) is rapidly transforming the biopharmaceutical industry, reshaping how drugs are discovered, developed, and delivered to patients. Traditionally, biopharma has been a time-consuming and expensive field, often requiring over a…

by R. Dream • August 20, 2026

COLUMN: PATENT STRATEGIES

The patentability of intermediate chemical compounds

Introduction The majority of chemical reactions are sequential processes, involving a series of steps, resulting in the formation of one or more intermediates. An intermediate structure may be considered a distinctive feature…

by M. Barbieri • August 20, 2026

ADC SYMPOSIUM

ADC Symposium Proceedings

AGENDA Two days dedicated to discussion and insights into the latest developments in the ADC field, featuring contributions from leading experts and industry professionals. Explore the full agenda to discover the sessions…

August 24, 2026

Latest Issue

Latest issue

Don’t stop here. There’s more waiting below.

BROWSE THE FLIPBOOK

BROWSE THE FLIPBOOK

Archive

For an even more in-depth scientific analysis, consult the archive

Content from magazine

Driving Next-Gen Biomanufacturing with Digital Transformation

Automation now the only option: Regulatory AI...

AI in Cell and Gene Therapy Manufacturing:...

Distress to Recovery: Solutions for EU Chemical...

Catalysis as a Key Technology for the...

Biocatalysis in the pharmaceutical industry: beyond sustainability,...

Advancing Flow Chemistry Scale-Up Through Integrated Chemical...

Subscribe and get free unlimited access!

Becoming the “Customer of Choice”: A Strategic Imperative for CDMOs and API Specialists

Intelligence Amplified: A CDMO Perspective on Integrating R&D and Manufacturing

Deriving health-based exposure limits for highly potent APIs: from regulatory expectation to expert toxicological judgement

HPAPI Management: From Categorization to Prevention – Practical Insights from the Spanish NTP 1104 & 1105 Framework

Scaling, Adapting and Partnering: How Europe’s Chemical Sector Can Stay Competitive in a Changing World

Regulatory affairs as the connective tissue of pharmaceutical product data

Advancing Antibody–Peptide Conjugates Through Controlled Conjugation and High Product Homogeneity

Baxdrostat (Baxfendy)

From data to decisions: How AI is transforming supply chains in chemical and pharmaceutical manufacturing

AI at Enterprise Scale: Inside Pharma’s Manufacturing Transformation

Artificial Intelligence in the Biopharma Industry

The patentability of intermediate chemical compounds

ADC Symposium Proceedings

Latest Issue

Latest issue

Don’t stop here. There’s more waiting below.

BROWSE THE FLIPBOOK

BROWSE THE FLIPBOOK

Archive

For an even more in-depth scientific analysis, consult the archive

Content from magazine

Most popular

Subscribe and get free unlimited access!

Login